YMN

1-[(3-iodanylphenyl)methyl]guanidine


Toggle HydrogenToggle Labels

Chemical Component Summary

Name1-[(3-iodanylphenyl)methyl]guanidine
Identifiers1-[(3-iodanylphenyl)methyl]guanidine
FormulaC8 H10 I N3
Molecular Weight275.09
TypeNON-POLYMER
Isomeric SMILES[H]/N=C(/N)\NCc1cccc(c1)I
InChIInChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)
InChIKeyPDWUPXJEEYOOTR-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count22
Chiral Atom Count0
Bond Count22
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB06704 
NameIobenguane
Groups
  • approved
  • investigational
DescriptionSynthetic guanethidine derivative that locates phaeochromocytomas and neuroblastomas. The radioisotope used can either be iodine-123 for imaging or iodine-131 for destruction of tissues that metabolize noradrenaline. Iodine 123 is a cyclotron-produced radionuclide that decays to Te 123 by electron capture. Images are produced by a I123 MIBG scintigraphy. FDA approved on September 19, 2008.
Synonyms
  • Iobenguane sulfate
  • m-iodobenzylguanidine
  • Iobenguane
  • Iobenguane sulfate I 131
  • mIBG
Brand Names
  • Azedra
  • AdreView
  • Iobenguane Sulfate I 131 Injection
IndicationDetection of primary and metastatic pheochromocytoma or neuroblastoma
Categories
  • Amidines
  • Benzene Derivatives
  • Compounds used in a research, industrial, or household setting
  • Diagnostic Radiopharmaceuticals
  • Diagnostic Uses of Chemicals
ATC-Code
  • V09IX01
  • V09IX02
  • V10XA02
CAS number80663-95-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Sodium-dependent noradrenaline transporterMLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682